Correction To: SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c—Translating Evidence Into Practice
Diabetes Therapy - United States
doi 10.1007/s13300-019-0670-y
Full Text
Open PDFAbstract
Available in full text
Date
July 18, 2019
Authors
Publisher
Springer Science and Business Media LLC